Study of Personalized Neoantigen Specific TCR T cells in the Treatment of Advanced Solid Cancers

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-518201-18-00

Acronym

NT-125-101

Enrollment

Registered

2024-12-02

Start date

2022-04-28

Completion date

2025-06-11

Last updated

2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Solid Cancers

None listed

Sex/Gender

All

Age

18 Years to No maximum

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026